-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Paradigm Shifts in the Reversal of DOACs

Program: Scientific Program
Session: Paradigm Shifts in Hemostasis: From Mechanisms to Therapies and Back
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Clinical trials, Translational Research, Assays, Clinical Research, Computational biology
Sunday, December 8, 2024, 4:30 PM-5:45 PM

Daniël Verhoef, MSc, PhD

VarmX B.V., Leiden, Netherlands; Leiden University Medical Center, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden, Netherlands

Disclosures: Verhoef: VarmX B.V.: Current Employment, Current holder of stock options in a privately-held company.